Kane Biotech Announces Positive Efficacy Results in STEM Pet Oral Care Clinical Trial
March 10, 2021 08:00 ET
|
Kane Biotech Inc.
WINNIPEG, Manitoba, March 10, 2021 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX- V:KNE; OTCQB:KNBIF) (the “Company” or “Kane”), announced today that preliminary analysis of data from efficacy trials...
Kane Biotech Announces New Chairman
February 24, 2021 08:45 ET
|
Kane Biotech Inc.
WINNIPEG, Manitoba, Feb. 24, 2021 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX- V:KNE; OTCQB:KNBIF) (the “Company” or “Kane Biotech”), announced today current Board member Mark Nawacki will take over...
Kane Biotech Announces Launch of New Human Health OTC DermaKB™ Product Line
December 10, 2020 08:30 ET
|
Kane Biotech Inc.
WINNIPEG, Manitoba, Dec. 10, 2020 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX- V:KNE; OTCQB:KNBIF) (the “Company” or “Kane Biotech”), a biotechnology company engaged in the research, development and...
Kane Biotech Announces Third Quarter 2020 Financial Results
November 26, 2020 17:31 ET
|
Kane Biotech Inc.
WINNIPEG, Manitoba, Nov. 26, 2020 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX- V:KNE; OTCQB:KNBIF) (the “Company” or “Kane Biotech”), a biotechnology company engaged in the research, development and...
Kane Biotech to Release Third Quarter 2020 Financial Results on November 26 – Conference Call to Follow
November 19, 2020 17:30 ET
|
Kane Biotech Inc.
WINNIPEG, Manitoba, Nov. 19, 2020 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX- V:KNE; OTCQB:KNBIF) (the “Company” or “Kane Biotech”), a biotechnology company engaged in the research, development and...
STEM Animal Health Appoints New President and CEO
October 13, 2020 08:00 ET
|
Kane Biotech Inc.
WINNIPEG, Manitoba, Oct. 13, 2020 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX-V:KNE; OTCQB:KNBIF) (“Kane Biotech”) today announced that Kevin Cole will assume the role of President and CEO of STEM...
Kane Biotech Appoints New Advisor
September 23, 2020 08:00 ET
|
Kane Biotech Inc.
WINNIPEG, Manitoba, Sept. 23, 2020 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX-V:KNE; OTCQB:KNBIF) (“Company,” “Kane Biotech”) today announced that it has entered into an agreement with Harbor Access...
ContraFect Partners with Leading Orthopedic Center in Europe to Provide Compassionate Use of Exebacase to Patients with Chronic Staphylococcal Prosthetic Joint Infections
January 13, 2020 08:00 ET
|
ContraFect Corporation
YONKERS, N.Y., Jan. 13, 2020 (GLOBE NEWSWIRE) -- ContraFect Corporation (Nasdaq:CFRX), a clinical-stage biotechnology company focused on the discovery and development of direct lytic agents (DLAs),...
Organogenesis to Sponsor Jan. 30 Webinar, “Chronic Wounds and Biofilms: Advancing Assessment and Treatment,” Featuring Dr. Gregory Schultz
January 24, 2019 10:00 ET
|
Organogenesis Holdings Inc.
CANTON, Mass., Jan. 24, 2019 (GLOBE NEWSWIRE) -- Organogenesis Holdings Inc. (Nasdaq: ORGO), a leading regenerative medicine company focused on the development, manufacture and commercialization of...
Wonder Dressing Saved my Foot
July 17, 2017 11:19 ET
|
Crawford Healthcare
DOYLESTOWN, Pa. and CHESHIRE, U.K., July 17, 2017 (GLOBE NEWSWIRE) -- A 47-year-old Indianapolis, Indiana woman has had her foot saved from amputation just hours before undergoing surgery, thanks to...